About 25 MCG Glyycopyrronium Inhalation Solution
Discover a masterful solution for COPD management with 25 MCG Glycopyrronium Inhalation Solution. This fresh, clear, and colorless liquid is designed for cost-effective maintenance therapy, ensuring long-lasting savings for adults in need of reliable bronchodilation. Each sterile, preservative-free ampoule delivers a lofty dosage exactly as prescribed, supporting optimal airway patency. Manufactured at WHO-GMP certified facilities in India, this crowning achievement in respiratory care exemplifies uncompromising quality and safety, delivering comfort and confidence with every use. Ideal for regular inhalation and suitable for chronic use under medical guidance.
Targeted Relief with Glycopyrronium Inhalation Solution
25 MCG Glycopyrronium Inhalation Solution is specifically formulated for adults with Chronic Obstructive Pulmonary Disease (COPD). Application surface includes the respiratory tract, administered via nebulization for direct lung delivery. Its competitive advantages include masterful sterility, quality assurance from WHO-GMP certified manufacturing, and preservative-free formulation. Use is straightforward: one unit-dose ampoule daily, supporting both maintenance and symptom control. It is ideal for general and specific use as prescribed, making it essential in long-term respiratory therapy.
Packaging Details, Sale Policy & Export Markets
Available in unit-dose plastic ampoules, each box contains 28 ampoules of Glycopyrronium Inhalation Solution. Handover is prompt, following clear order protocols, and sample policy is available by request. Asking price and sale price are competitive, reflecting both quality and cost-efficiency. The primary export markets include Asia, Africa, and various global healthcare sectors. Packaging ensures product integrity and safety, delivered below 25C and protected from light and moisture to maintain potency and efficacy.
FAQ's of 25 MCG Glyycopyrronium Inhalation Solution:
Q: How should 25 MCG Glycopyrronium Inhalation Solution be administered for COPD management?
A: It should be administered via nebulization or a suitable inhalation device, using one unit-dose ampoule as prescribed by your physician, typically once daily.
Q: What are the key competitive advantages of this inhalation solution?
A: Its advantages include a sterile, preservative-free liquid, WHO-GMP certified manufacturing, cost-effective packaging, and direct lung delivery for optimal bronchodilation.
Q: When should the solution be used after opening the ampoule?
A: The solution should be used immediately after opening the ampoule to maintain sterility and efficacy.
Q: Where is Glycopyrronium Inhalation Solution manufactured?
A: This product is manufactured at trusted facilities in India, adhering to WHO-GMP quality standards.
Q: What is the main function of 25 MCG Glycopyrronium Inhalation Solution?
A: It serves as a bronchodilator, helping maintain airflow and reduce obstructive symptoms in adults diagnosed with COPD.
Q: Is this inhalation solution suitable for children?
A: No, it is recommended only for adult use as a maintenance therapy for COPD as prescribed by a healthcare professional.